Happening tonight! ANMS Pearls of Wisdom: How an APP Utilizes AI Programs (ChaptGPT; GastroGPT) in an NGM Practice.
Moderator: Jason R. Baker, PhD, AnX Robotica
Invited Speaker: Eva Kinzer, FNP, Atrium Health
Register at https://t.co/gFarDjbgfS
Join us for our ANMS Virtual Webinar ANMS Basic Science Virtual Symposium: Basic science underlying drug development or clinical practice.
Wednesday, March 18, 2026
6:00 pm ET / 5:00 pm CT / 3:00 pm PT
Moderators: Faranak Fattahi, PhD and Madhu Grover, MBBS
Arashdeep Singh, PhD, Research Diets, Inc. Transcriptome-Guided GLP-1 Receptor Therapy for Metabolic Rescue in Bardet–Biedl Syndrome
Jay Pasricha, MD, Mayo Scottsdale “Valium" for the gut- a novel drug platform for treating visceral pain and related symptoms
https://t.co/jq7uviwarq
Join us for our ANMS Virtual Webinar ANMS Basic Science Virtual Symposium: Basic science underlying drug development or clinical practice
Wednesday, March 18, 2026
6:00 pm ET / 5:00 pm CT / 3:00 pm PT
Moderators: Faranak Fattahi, PhD and Madhu Grover, MBBS
Speakers: Arashdeep Singh, PhD, Research Diets, Inc.
Transcriptome-Guided GLP-1 Receptor Therapy for Metabolic Rescue in Bardet–Biedl Syndrome
Jay Pasricha, MD, Mayo Scottsdale
“Valium" for the gut- a novel drug platform for treating visceral pain and related symptoms
In our study https://t.co/ugGCcjYKnF @jclinicalinvest we uncover a previously unrecognized role for the small intestinal #microbiome in driving #abdominal pain, calling for targeted modulation of small intestinal bacteria rather than using broad spectrum antibiotics @MayoClinic
🆕🔥Smartphone #application with #HealthCoaching facilitates multi-symptom improvement in #IBS patients‼️
🎯Mobile health #mHealth platforms #LyfeMD have potential to improve symptom severity, psychosocial wellbeing, & sleep👏
👉https://t.co/9ShVNTQppd
@ANMSociety@esnm_eu
🆕🔥Beyond #Malabsorption: Need for Symptom-Based Assessment in Suspected #LactoseIntolerance‼️
🎯Breath test–proven malabsorption does not reliably predict symptoms🔥
🎯Integration of #PatientReportedOutcomes provides a more comprehensive assessment👏
👉https://t.co/rj4FrbRqn1
🔔Announcing the recruitment for the inaugural Mass General Brigham Advanced Fellowship in Neurogastroenterology and Motility Disorders at both @MGH_GI and @BrighamGI. Building upon the existing MGH Advanced Fellowship in Functional and Gastrointestinal Motility Disorders, we seek board eligible/board certified gastroenterologists for this career opportunity.
To apply: contact Program Director Dr. Christopher Velez at [email protected] and Associate Director Dr. Jennifer Cai at [email protected].
More details on the program and application process:
Fellows will train with one of the largest academic GI motility faculties in the world. Focused on clinical care, education & research, a graduate of this fellowship will be highly competitive when seeking post-training positions. Recent graduates of this program have joined faculty nationally, including at Stanford, New York Presbyterian-Cornell, Massachusetts General Hospital, Mayo Clinic Jacksonville, Boston Medical Center, Advent Health, among other institutions.
Eligibility requirements:
1. Have graduated from an accredited U.S. gastroenterology fellowship program and be able to independently perform endoscopy by June 30th, 2026.
2. Be able to start July 1st, 2026 and train through June 30th, 2027, and obtain a full physician license from the Massachusetts Board of Registration in Medicine by February 2026.
3. Provide a personal statement of interest, curriculum vitae, and 2 letters of reference.
4. Apply by the deadline of Friday, October 31st, 2025. Applications will be reviewed on a rolling basis.
5. Interview virtually during November 2025 with a targeted notification date of acceptance by Monday, December 1st, 2025.